Activation of the PI3K/mTOR/AKT Pathway and Survival in Solid Tumors: Systematic Review and Meta-Analysis

• Alberto Ocana ,

  * E-mail: albertoo@sescam.jccm.es

  Affiliation Translational Research Unit, Albacete University Hospital, Albacete, Spain

  ⨯
• Francisco Vera-Badillo,

  Affiliation Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada

  ⨯
• Mustafa Al-Mubarak,

  Affiliation Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada

  ⨯
• Arnoud J. Templeton,

  Affiliation Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada

  ⨯
• Verónica Corrales-Sanchez,

  Affiliation Translational Research Unit, Albacete University Hospital, Albacete, Spain

  ⨯
• Laura Diez-Gonzalez,

  Affiliation Translational Research Unit, Albacete University Hospital, Albacete, Spain

  ⨯
• María D. Cuenca-Lopez,

  Affiliation Translational Research Unit, Albacete University Hospital, Albacete, Spain

  ⨯
• Bostjan Seruga,

  Affiliation Sector of medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

  ⨯
• Atanasio Pandiella,

  Affiliation Centro de Investigación del Cáncer, CSIC-University of Salamanca, Salamanca, Spain

  ⨯
• Eitan Amir

  Affiliation Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada

  ⨯